Global Technologies Ltd. Reports 66% Revenue Decline and Increased Operating Losses for Six Months Ending December 31, 2025

Global Technologies Ltd. reported a significant decline in financial performance for the six months ending December 31, 2025, compared to the same period in 2024. The company generated total revenue of $541,293, a decrease of 66% from $1,586,508 in the prior year. The net revenue for the second quarter was $136,347, slightly up from $134,582 in the same quarter of 2024. The company recorded a net income of $21,439 for the six months, a sharp decline from $217,352 in the previous year, reflecting a challenging operational environment and strategic shifts within its business model.

The financial results indicate a notable increase in operating expenses, which rose to $478,462 from $375,702 year-over-year, primarily driven by higher selling, general, and administrative costs. The company’s loss from operations for the six months was $245,187, contrasting with a profit of $236,422 in the same period last year. The increase in expenses was attributed to the transition of its Primecare Supply subsidiary from a wholesale procurement model to a direct-to-clinic sales strategy, which, while expected to enhance long-term profitability, has initially resulted in lower revenue.

Strategically, Global Technologies has made significant organizational changes, including the establishment of Primecare Supply, LLC, which commenced operations in May 2025. This subsidiary aims to modernize the pharmaceutical supply chain by connecting licensed manufacturers with medical clinics. The company also formed GTLL Advisory Group, LLC, which is set to begin operations in fiscal year 2026, focusing on consulting services for small and mid-sized enterprises in the health and wellness sectors. However, the company terminated its acquisition of GOe3, LLC, due to unmet operational milestones, reallocating resources to its core business segments.

Operationally, the company has seen a shift in its customer base and engagement metrics. Primecare Supply has established relationships with multiple 503B manufacturers and hundreds of clinics, although the transition to a direct sales model has resulted in slower initial revenue growth. As of December 31, 2025, the company had cash and cash equivalents of $41,408, down from $68,108 at the end of June 2025, indicating a cash burn rate that raises concerns about liquidity. The company reported cash used in operating activities of $226,600 for the six months, compared to cash provided of $98,489 in the previous year.

Looking ahead, Global Technologies faces substantial challenges, including a history of net losses and ongoing cash flow issues. The company has acknowledged the need for additional funding sources to support its operations and growth initiatives. Management is exploring various options, including corporate partnerships and equity financing, to mitigate these challenges. However, there remains significant uncertainty regarding the company's ability to generate sufficient cash flow from operations or secure necessary funding, which could impact its future viability.